Another implication of the current results is that T4, the natural ligand of the thyroid hormone αvβ3 (thyrointegrin) receptor, may support metabolism in tumor cells and actively angiogenic blood vessel cells that serve tumors [4]. This evidence concerns the gene CD4 and neoplasm.